1. Home
  2. MNOV

MNOV

Medicinova Inc

Logo Medicinova Inc

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-12-2024 11:34am EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

MediciNova Inc is a biopharmaceutical company. The company acquires and develops small-molecule therapeutics for the treatment of diseases with unmet medical needs with a specific focus on the U.S. market. Its products portfolio includes therapeutics such as MN-001, MN-166, MN-221 etc. The firm's current strategy is to focus its development activities on therapeutics for neurological disorders and fibrotic diseases.

Founded: 2000 Country:
United States
United States
Employees: 13 City: LA JOLLA
Market Cap: 76.5M IPO Year: 2005
Target Price: N/A AVG Volume (30 days): 52.6K
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -0.17 EPS Growth: N/A
52 Week Low/High: $1.26 - $2.66 Next Earning Date: 05-09-2024
Revenue: $1,000,000 Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

Share on Social Networks: